M. Miyamae

发表

Gastric carcinoma originating from the heterotopic submucosal gastric gland treated by laparoscopy and endoscopy cooperative surgery.

D. Ichikawa, E. Otsuji, N. Yagi, 2015, World journal of gastrointestinal oncology.

Discrepancies in the histologic type between biopsy and resected specimens: a cautionary note for mixed-type gastric carcinoma.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2015, World journal of gastroenterology.

Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2015, World journal of gastroenterology.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Oncotarget.

Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, Anticancer research.

Syndactyly and preaxial synpolydactyly in the single Sfrp2 deleted mutant mice

R. Matsui, J. Toguchida, K. Tashiro, 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

Histological mixed-type as an independent risk factor for nodal metastasis in submucosal gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2015, Tumor Biology.

Clinical Impact of Predicting CCND1 Amplification Using Plasma DNA in Superficial Esophageal Squamous Cell Carcinoma

D. Ichikawa, E. Otsuji, N. Yagi, 2014, Digestive Diseases and Sciences.

Malignant potential in pancreatic neoplasm: new insights provided by circulating mir-223 in plasma

D. Ichikawa, H. Taniguchi, E. Otsuji, 2015 .

Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, Oncotarget.

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, International journal of molecular sciences.

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Oncotarget.

Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma

D. Ichikawa, H. Taniguchi, E. Otsuji, 2015, Expert opinion on biological therapy.

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, World journal of gastroenterology.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Scientific Reports.

Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function

D. Ichikawa, H. Taniguchi, E. Otsuji, 2016, Oncotarget.

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer

D. Ichikawa, H. Taniguchi, E. Otsuji, 2015, British Journal of Cancer.

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma

T Kawaguchi, D. Ichikawa, E. Otsuji, 2014, British Journal of Cancer.

Circulating miR-18a: a sensitive cancer screening biomarker in human cancer.

Shuhei Komatsu, Atsushi Shiozaki, Eigo Otsuji, 2014, In vivo.

A Case Study of Intestinal Obstruction Associated with True Primary Enteroliths in an Elderly Patient

E. Otsuji, H. Inoue, Y. Kokawa, 2021 .

Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2015, Oncotarget.

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, World journal of gastroenterology.

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, British Journal of Cancer.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, Carcinogenesis.

Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, American journal of cancer research.

Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, Journal of Gastrointestinal Surgery.

Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Anticancer research.

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

J. Inazawa, H. Tsuda, I. Imoto, 2014, British Journal of Cancer.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

D. Ichikawa, H. Taniguchi, E. Otsuji, 2017, Scientific Reports.

Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, American journal of cancer research.